In Australia, a government advisory committee* determines whether to recommend that a medicine should be subsidised.
As part of its decision-making process, this committee invites people with the condition, as well as their carer/s and family, to have their say on how this medicine would benefit them.
Once this committee provides a positive recommendation, it is then up to the Federal Government to list the medicine on the Pharmaceutical Benefits Scheme (PBS).
This is a separate process to how medicines are registered for use in Australia. Medicines that are registered are deemed to be effective and safe for use, but medicines often need to be publicly funded before they are affordable to most Australians.
*PBAC = Pharmaceutical Benefits Advisory Committee